Literature DB >> 11390698

Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations.

P Duriez1, O Clermont, S Bonacorsi, E Bingen, A Chaventré, J Elion, B Picard, E Denamur.   

Abstract

An intraspecies phylogenetic grouping of 168 human commensal Escherichia coli strains isolated from the stools of three geographically distinct human populations (France, Croatia, Mali) was generated by triplex PCR. The distributions of seven known extraintestinal virulence determinants (ibeA, pap, sfa/foc, afa, hly, cnf1, aer) were also determined by PCR. The data from the three populations were compiled, which showed that strains from phylogenetic groups A (40%) and B1 (34%) were the most common, followed by phylogenetic group D strains (15%). Strains of the phylogenetic group B2 were rare (11%). However, a significant specific distribution for strains of groups A, B1 and B2 within each population was observed, which may indicate the influence of (i) geographic/climatic conditions, (ii) dietary factors and/or the use of antibiotics or (iii) host genetic factors on the commensal flora. Virulence determinants were rarely detected, with only 25.6% of the strains harbouring at least one of the virulence genes tested. The strains with virulence factors most frequently belonged to phylogenetic group B2. The commensal strains of phylogenetic groups A, B1 and D had fewer virulence determinants than pathogenic strains of the corresponding groups when these data were compared with those for previous collections of virulent extraintestinal infection strains studied using the same approach. However, the virulence patterns of commensal and pathogenic B2 phylogenetic group strains were the same. The data thus suggest that strains of the A, B1 and D phylogenetic groups predominate in the gut flora and that these strains must acquire virulence factors to become pathogenic. In contrast, commensal phylogenetic group B2 strains are rare but appear to be potentially virulent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390698     DOI: 10.1099/00221287-147-6-1671

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  107 in total

1.  Pathogenic Escherichia coli found in sewage treatment plants and environmental waters.

Authors:  E M Anastasi; B Matthews; H M Stratton; M Katouli
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

2.  Distribution of human commensal Escherichia coli phylogenetic groups.

Authors:  Jannine K Bailey; Jeremy L Pinyon; Sashindran Anantham; Ruth M Hall
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

3.  Comparative prevalence of Escherichia coli carrying virulence genes and class 1 and 2 integrons in sub-tropical and cool temperate freshwater.

Authors:  Jatinder P S Sidhu; Paul Jagals; Amy Smith; Simon Toze
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-21       Impact factor: 4.223

4.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease.

Authors:  Roman Kotlowski; Charles N Bernstein; Shadi Sepehri; Denis O Krause
Journal:  Gut       Date:  2006-10-06       Impact factor: 23.059

5.  The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro.

Authors:  Friederike Feldmann; Liisa Johanna Sorsa; Kirsten Hildinger; Sören Schubert
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

6.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

7.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

8.  Molecular Characterization of Uropathogenic Escherichia coli: Nalidixic Acid and Ciprofloxacin Resistance, Virulent Factors and Phylogenetic Background.

Authors:  Shreya Basu; Sandip Kumar Mukherjee; Avijit Hazra; Mandira Mukherjee
Journal:  J Clin Diagn Res       Date:  2013-12-15

9.  Multi-omics Quantification of Species Variation of Escherichia coli Links Molecular Features with Strain Phenotypes.

Authors:  Jonathan M Monk; Anna Koza; Miguel A Campodonico; Daniel Machado; Jose Miguel Seoane; Bernhard O Palsson; Markus J Herrgård; Adam M Feist
Journal:  Cell Syst       Date:  2016-09-22       Impact factor: 10.304

10.  Escherichia coli strains from pregnant women and neonates: intraspecies genetic distribution and prevalence of virulence factors.

Authors:  Stéphane Watt; Philippe Lanotte; Laurent Mereghetti; Maryvonne Moulin-Schouleur; Bertrand Picard; Roland Quentin
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.